Novel cancer stem cell therapy on the horizon.
Sapi
Eva
E
Department of Biology and Environmental Sciences, University of New Haven, West Haven, CT 06516, USA. esapi@newhaven.edu
D017209:Apoptosis / Q000187:drug effects*; D002219:Carbamates / Q000737:chemistry / Q000494:pharmacology*; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects*; D002470:Cell Survival / Q000187:drug effects; D002867:Chromones / Q000737:chemistry / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004847:Epithelial Cells / Q000473:pathology; D005260:Female; D006801:Humans; D007529:Isoflavones / Q000737:chemistry / Q000494:pharmacology*; D014411:Neoplastic Stem Cells / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D010051:Ovarian Neoplasms / Q000378:metabolism / Q000473:pathology; D013997:Time Factors
C527125:5-(2-(3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yloxy)acetylamino)hexylcarbamic acid tert-butyl ester; D002219:Carbamates; D002867:Chromones; D007529:Isoflavones; C004742:daidzein